147 related articles for article (PubMed ID: 15342407)
41. miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines.
Zhu W; Shan X; Wang T; Shu Y; Liu P
Int J Cancer; 2010 Dec; 127(11):2520-9. PubMed ID: 20162574
[TBL] [Abstract][Full Text] [Related]
42. Induction of apoptosis in lung-cancer cells following bcl-xL anti-sense treatment.
Leech SH; Olie RA; Gautschi O; Simões-Wüst AP; Tschopp S; Häner R; Hall J; Stahel RA; Zangemeister-Wittke U
Int J Cancer; 2000 May; 86(4):570-6. PubMed ID: 10797273
[TBL] [Abstract][Full Text] [Related]
43. Proteinase-3, a serine protease which mediates doxorubicin-induced apoptosis in the HL-60 leukemia cell line, is downregulated in its doxorubicin-resistant variant.
Wu CH; Gordon J; Rastegar M; Ogretmen B; Safa AR
Oncogene; 2002 Aug; 21(33):5160-74. PubMed ID: 12140766
[TBL] [Abstract][Full Text] [Related]
44. Induced resistance in the human non small cell lung carcinoma (NCI-H460) cell line in vitro by anticancer drugs.
Pesic M; Markovic JZ; Jankovic D; Kanazir S; Markovic ID; Rakic L; Ruzdijic S
J Chemother; 2006 Feb; 18(1):66-73. PubMed ID: 16572896
[TBL] [Abstract][Full Text] [Related]
45. Modulation of doxorubicin resistance in multidrug-resistance cells by targeted liposomes combined with hyperthermia.
Gaber MH
J Biochem Mol Biol Biophys; 2002 Oct; 6(5):309-14. PubMed ID: 12385965
[TBL] [Abstract][Full Text] [Related]
46. Medicarpin and millepurpan, two flavonoids isolated from Medicago sativa, induce apoptosis and overcome multidrug resistance in leukemia P388 cells.
Gatouillat G; Magid AA; Bertin E; El btaouri H; Morjani H; Lavaud C; Madoulet C
Phytomedicine; 2015 Dec; 22(13):1186-94. PubMed ID: 26598918
[TBL] [Abstract][Full Text] [Related]
47. Expression of the multidrug resistance-associated protein 1 (MRP1) and the lung resistance-related protein (LRP) in human lung cancer.
Rybárová S; Hajduková M; Hodorová I; Kocisová M; Böör A; Brabencová E; Kasan P; Biros E; Mojzis J; Mirossay L
Neoplasma; 2004; 51(3):169-74. PubMed ID: 15254668
[TBL] [Abstract][Full Text] [Related]
48. A P-glycoprotein- and MRP1-independent doxorubicin-resistant variant of the MCF-7 breast cancer cell line with defects in caspase-6, -7, -8, -9 and -10 activation pathways.
Park SJ; Wu CH; Safa AR
Anticancer Res; 2004; 24(1):123-31. PubMed ID: 15015586
[TBL] [Abstract][Full Text] [Related]
49. Liposomal delivery of antisense oligonucleotides for efficient downregulation of Bcl-2 and induction of apoptosis.
Buck AC; Shen C; Schirrmeister H; Schmid-Kotsas A; Munzert G; Guhlmann A; Mehrke G; Klug N; Gross HJ; Bachem M; Reske SN
Cancer Biother Radiopharm; 2002 Jun; 17(3):281-9. PubMed ID: 12136520
[TBL] [Abstract][Full Text] [Related]
50. Localization of a novel multidrug resistance-associated gene in the HT1080/DR4 and H69AR human tumor cell lines.
Slovak ML; Ho JP; Bhardwaj G; Kurz EU; Deeley RG; Cole SP
Cancer Res; 1993 Jul; 53(14):3221-5. PubMed ID: 8391919
[TBL] [Abstract][Full Text] [Related]
51. Co-transfection of MRP and bcl-2 antisense S-oligodeoxynucleotides reduces drug resistance in cisplatin-resistant lung cancer cells.
Wang J; Liu X; Jiang W
Chin Med J (Engl); 2000 Oct; 113(10):957-60. PubMed ID: 11775848
[TBL] [Abstract][Full Text] [Related]
52. The role of a novel copper complex in overcoming doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
Majumder S; Dutta P; Mookerjee A; Choudhuri SK
Chem Biol Interact; 2006 Feb; 159(2):90-103. PubMed ID: 16289015
[TBL] [Abstract][Full Text] [Related]
53. Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cells.
Minko T; Batrakova EV; Li S; Li Y; Pakunlu RI; Alakhov VY; Kabanov AV
J Control Release; 2005 Jul; 105(3):269-78. PubMed ID: 15939500
[TBL] [Abstract][Full Text] [Related]
54. Modulation of multidrug resistance-associated protein 1 (MRP1) by p53 mutant in Saos-2 cells.
Tsang WP; Chau SP; Fung KP; Kong SK; Kwok TT
Cancer Chemother Pharmacol; 2003 Feb; 51(2):161-6. PubMed ID: 12647018
[TBL] [Abstract][Full Text] [Related]
55. Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines.
Wang J; Zhang J; Zhang L; Zhao L; Fan S; Yang Z; Gao F; Kong Y; Xiao GG; Wang Q
Oncol Rep; 2011 Nov; 26(5):1081-9. PubMed ID: 21805041
[TBL] [Abstract][Full Text] [Related]
56. Simultaneous suppression of multidrug resistance and antiapoptotic cellular defense induces apoptosis in chemoresistant human acute myeloid leukemia cells.
Wang X; Wang C; Qin YW; Yan SK; Gao YR
Leuk Res; 2007 Jul; 31(7):989-94. PubMed ID: 17067671
[TBL] [Abstract][Full Text] [Related]
57. Antagonist G-mediated targeting and cytotoxicity of liposomal doxorubicin in NCI-H82 variant small cell lung cancer.
Moreira JN; Gaspar R
Braz J Med Biol Res; 2004 Aug; 37(8):1185-92. PubMed ID: 15273819
[TBL] [Abstract][Full Text] [Related]
58. MRP gene overexpression in a human doxorubicin-resistant SCLC cell line: alterations in cellular pharmacokinetics and in pattern of cross-resistance.
Binaschi M; Supino R; Gambetta RA; Giaccone G; Prosperi E; Capranico G; Cataldo I; Zunino F
Int J Cancer; 1995 Jul; 62(1):84-9. PubMed ID: 7601572
[TBL] [Abstract][Full Text] [Related]
59. Modulation of doxorubicin cytotoxicity by ethacrynic acid.
Awasthi S; Singhal SS; He N; Chaubey M; Zimniak P; Srivastava SK; Singh SV; Awasthi YC
Int J Cancer; 1996 Nov; 68(3):333-9. PubMed ID: 8903475
[TBL] [Abstract][Full Text] [Related]
60. Development of a double-layer microfluidic chip with flow medium for chemotherapy resistance analysis of lung cancer.
Meng Q; He Z; Zhang L; Zhao L; Li E; Zhang Q; Zhang X; Yang D; Zou L; Gao Z; Wang Q
Electrophoresis; 2011 Nov; 32(23):3446-53. PubMed ID: 22072486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
